investment highlights
focused portfolio in attractive end markets
innovation that solves customer challenges
operational excellence and cost discipline
strong cash generation and discipline capital allocation
capital return
sales1

adjusted EBITDA1

adjusted EBITDA margin1

1Sales, adjusted EBITDA and adjusted EBITDA margins were all impacted by our Portfolio Optimization initiatives. Actions such as curtailing or divesting lower margin products and rationalizing product lines reduced sales by approximately $208 million and adjusted EBITDA by $45 million, while improving adjusted EBITDA margins by 30 basis points in fiscal year 2025 compared to 2024.
All figures are presented on an adjusted basis. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of this Annual Report reconciles adjusted amounts to amounts reported under GAAP, including reconciliations of net income to EBITDA and adjusted EBITDA, operating income to adjusted operating income, income from continuing operations to adjusted income from continuing operations, diluted earnings per share to adjusted diluted earnings per share and adjusted diluted earnings per share, excluding amortization expense.







